Overview
Clinical Images
Documents
Training
HEALTH NEWS HIGHLIGHT:
New FDA Guidelines Require
Breast Density Reporting
AEµç×Ó has more solutions that help radiologists identify and detect breast cancer in women with dense breasts.
AEµç×Ó and Bayer join forces to provide a coordinated Contrast-Enhanced Mammography solution
A better 3D™ breast screening experience – for everyone.
The new 3Dimensions system is designed to provide higher quality 3D images for radiologists, a more comfortable mammography experience for patients and enhanced workflow for technologists. Discover how sharper images and smarter technologies continue to help find invasive cancers regardless of age or breast density.1-6
Designed to be the fastest, highest resolution breast tomosynthesis system, ever.
The new 3Dimensions mammography system matches the unrivaled performance of our Genius 3D Mammographyâ„¢ exam, which is more accurate than conventional 2D mammograms, detecting 20%-65% more invasive breast cancers.1-8 Breakthrough improvements transform the patient experience without compromising speed or accuracy.
Better visibility
Designed to improve visibility of fine details for greater diagnostic confidence.*
More comfortable
Clinically proven to deliver a more comfortable mammogram.7
Improves the patient experience with a curved compression surface that mirrors the shape of the breast for a more even compression
More efficient
Enables technologists to conduct fast, efficient exams and accelerate reading time to streamline workflow.**
Video Resources
More about our product:
For patients:
Beyond Screening: Breast Cancer Index® Test
As breast cancer survivors continue to get regular screenings throughout survivorship, understanding long term treatment plans is also essential. The Breast Cancer Index® test helps determine if a patient with HR+, early-stage breast cancer is likely to benefit from extending endocrine therapy to 10 years, or if she can stop at the 5-year mark and avoid potential side effects.
Product Images
